tiprankstipranks
Trending News
More News >
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market

Oncopeptides AB (ONCO) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Oncopeptides AB’s (ONCO) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting Oncopeptides AB is a Buy.
Oncopeptides AB’s (ONCO) 20-Day exponential moving average is 1.91, while Oncopeptides AB’s (ONCO) share price is kr2, making it a Buy.
Oncopeptides AB’s (ONCO) 50-Day exponential moving average is 1.81, while Oncopeptides AB’s (ONCO) share price is kr2, making it a Buy.

Oncopeptides AB (ONCO) Pivot Points

May 18, 2025, 09:05 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.78
1.84
1.89
1.95
2.01
2.06
2.12
Fibonacci
1.84
1.88
1.91
1.95
1.99
2.02
2.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Oncopeptides AB (ONCO) Moving Averages

May 18, 2025, 09:05 PM
Period
Simple
Exponential
MA5
1.96Buy
1.96Buy
MA10
1.91Buy
1.94Buy
MA20
1.93Buy
1.91Buy
MA50
1.76Buy
1.81Buy
MA100
1.64Buy
1.76Buy
MA200
1.80Buy
1.96Buy
Oncopeptides AB’s (ONCO) 10-Day exponential moving average is 1.94, while Oncopeptides AB’s (ONCO) share price is kr2, making it a Buy.
Oncopeptides AB’s (ONCO) 100-Day exponential moving average is 1.76, while Oncopeptides AB’s (ONCO) share price is kr2, making it a Buy.
Oncopeptides AB’s (ONCO) stock price is kr2 and Oncopeptides AB’s (ONCO) 50-day simple moving average is 1.76, creating a Buy signal.
Oncopeptides AB’s (ONCO) stock price is kr2 and Oncopeptides AB’s (ONCO) 100-day simple moving average is 1.64, creating a Buy signal.
Oncopeptides AB’s (ONCO) stock price is kr2 and Oncopeptides AB’s (ONCO) 200-day simple moving average is 1.80, creating a Buy signal.

Oncopeptides AB (ONCO) Technical Indicators

May 18, 2025, 09:05 PM
Name
Value
Implied Action
RSI (14)
60.72
Neutral
STOCH (9,6)
79.34
Neutral
STOCHRSI (14)
79.34
Neutral
MACD (12,26)
0.05
Buy
ADX (14)
44.89
Neutral
Williams %R
-16.53
Sell
CCI (14)
83.13
Neutral
ATR (14)
0.12
-
Ultimate Oscillator
54.49
Neutral
ROC
3.09
Buy
Oncopeptides AB’s (ONCO) Relative Strength Index (RSI) is 60.72, creating a Neutral signal.
Oncopeptides AB’s (ONCO) Trend Strength Indicator (ADX) is 44.89, creating a Neutral signal.
Oncopeptides AB’s (ONCO) Commodity Channel Index (CCI) is 83.13, creating a Neutral signal.
Oncopeptides AB’s (ONCO) Price Rate of Change (ROC) is 3.09, creating a Buy signal.

FAQ

Is ONCO a Buy, Hold, or Sell?
Based on ONCO’s technical indicators, ONCO is a Strong Buy.
    What is ONCO’s RSI (14)?
    ONCO’s RSI (14) is 60.72, which suggests ONCO is a Neutral.
      What is ONCO’s MACD?
      ONCO’s MACD is 0.05, which suggests ONCO is a Buy.
        What is ONCO’s 5-day moving average?
        ONCO’s 5-day moving average is 1.96, which suggests ONCO is a Buy.
          What is ONCO’s 20-day moving average?
          ONCO 20-day moving average is 1.93, which suggests ONCO is a Buy.
            What is ONCO’s 50-day moving average?
            ONCO’s 50-day moving average is 1.76, which suggests ONCO is a Buy.
              What is ONCO’s 200-day moving average?
              ONCO’s 200-day moving average is 1.80, which suggests ONCO is a Buy.
                What is ONCO’s Williams % R (14)?
                ONCO’s Williams % R (14) is -16.53, which suggests ONCO is a Sell.
                  What is ONCO’s CCI (14)?
                  ONCO’s CCI (14) is 83.13, which suggests ONCO is a Neutral.
                    What is the share price of Oncopeptides AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis